Covetrus Inc. Stock News

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing

Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two pri

Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.

CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.

Covetrus (CVET) delivered earnings and revenue surprises of 8.70% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

Covetrus (CVET) delivered earnings and revenue surprises of 4% and 1.40%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

At the JPMorgan Healthcare Conference, Covetrus (CVET) established initial 2022 adjusted EBITDA guidance of $270M-$280M, up from $245M-$255M guided for FY21 on November 4th.This

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Shares of Covetrus, Inc. (NASDAQ:CVET) have been given a consensus rating of Hold by the seven analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating on the company. The average []

Nisa Investment Advisors LLC trimmed its position in Covetrus, Inc. (NASDAQ:CVET) by 34.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,580 shares of the companys stock after selling 5,075 shares during the quarter. Nisa Investment Advisors LLCs holdings in Covetrus []

TheStreet lowered shares of Covetrus (NASDAQ:CVET) from a c- rating to a d+ rating in a research note released on Friday morning, TheStreetRatingsTable reports. CVET has been the topic of several other research reports. Zacks Investment Research lowered shares of Covetrus from a hold rating to a sell rating in a report on Tuesday, November []

Covetrus Inc. (NASDAQ:CVET) shares, rose in value on Friday, 11/26/21, with the stock price down by -2.58% to the previous days close as strong demand from buyers drove the stock to $17.78. Actively observing the price movement in the last trading, the stock closed the session at $18.25, falling within a range of $17.2501 and Analysts Predict An Covetrus Inc. (NASDAQ: CVET) Spike? Read More »

Covetrus, Inc. (NASDAQ:CVET) has earned a consensus recommendation of “Hold” from the six analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average twelve-month price target […]

Invesco Ltd. increased its position in Covetrus, Inc. (NASDAQ:CVET) by 5.9% in the 2nd quarter, Holdings Channel reports. The firm owned 834,153 shares of the companys stock after buying an additional 46,454 shares during the period. Invesco Ltd.s holdings in Covetrus were worth $22,522,000 as of its most recent filing with the SEC. Other institutional []